Cancer Studies and Molecular Medicine

Open journal

ISSN 2377-1518

National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Anastasis: Cell Survival Mechanism

Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu

Anticancer Natural Products: A Review

Ranwa A. Elrayess and Heba N. Gad El-Hak*

A Rare Case of a Urachal Mucinous Cystic Tumour of Low Malignant Potential

Kanchan K. Palial*, Bob Yang, Philip J. S. Charlesworth, Charles E. Lewis, Lisa Browning and Clare Verrill

Rounding Down Chemotherapeutic Agents to the Nearest Vial Size as a Cost Containment Measure

Yousef Al-Olah, Nasser Mahdi Al-Qhtani*, Maj Mohammed A. Al Waheeby, Abdul-Rahman I. Al-Ghamdi, Ghadah Al Yousif, Al Hanouf N. Al Dajani, Nourah M. Al Henaki and Ahlam M. Al Zahrani

Treatment of Stage I Seminoma

Milan Anjanappa, Cessal Thommachan Kainickal and Francis V. James*

MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis

Zhan-Guo Zhang, Yan-Hui Wu, Hui-Fang Liang, Bi-Xiang Zhang and Wan-Guang Zhang*

Role of Molecular Imaging in Oncology

Pradeep K. Garg*, Surinder K. Batra and Sudha Garg

Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

Yasuko Kitagishi*, Satoru Matsuda*, Akari Minami, Yuna Ono, Atsuko Nakanishi and Yasunori Ogura

Medicine, Perspective, Precision drugs, Precision medicine

2023 Feb

Karel Petrak*
National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Consensus, Guidelines, Hepatocellular carcinoma, Panama, Systematic Review

2022 Nov

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Antitumor agents, cancer, Chemotherapy, Drug development, Neoplasms, Opinion

2022 Oct

Daniel Gandia* and Cecilia Suarez
Anastasis: Cell Survival Mechanism

Anastasis, cancer, Programmed cell death, review

2020 Sep

Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu

cancer, Cancer Dynamics, Immunotherapy, Oncogenes, Opinion, Therapeutics, Tumor suppressor genes

2020 May

Daniel Gandia* and Cecilia Suárez

cancer, Editorial, NF1, NF1 Plasma Membrane, Pathology

2020 Mar

Vincent M. Riccardi*

cancer, Chemotherapy, Heterogeneity, Opinion, Phenotype, Resistance

2019 Oct

Daniel Gandia*
Oligo-Metastatic Carcinoma Cervix: A Few Do Extremely Well

Carcinoma, Case Series, Cervix, Chemotherapy, Oligometastasis

2019 Aug

Pallavi Nair and Francis V. James*

Anticancer, Natural product;, review, Venom

2019 Aug

Ranwa A. Elrayess and Heba N. Gad El-Hak*
Deep-Ultraviolet Raman Spectroscopy for Cancer Diagnostics: A Feasibility Study with Cell Lines and Tissues

Cancer diagnostics, Deep-ultraviolet resonance Raman spectroscopy, Original Research, Prostate Cancer

2019 Apr

Nicole M. Ralbovsky, Vladimir Egorov, Eugene Moskovets, Paromita Dey, Bijan K. Dey and Igor K. Lednev*

African American Community, Breast cancer, Editorial

2019 Apr

Jennifer Sims-Mourtada*, Zohra Ali-Khan Catts, Patricia Swanson and Nora Katurakes
The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy

Early life exposure, Environmental factors, Systematic Review, Uterine fibroids

2018 Sep

Qiwei Yang*, Mohamed Ali, Abdeljabar El Andaloussi, Ayman Al-Hendy
A Case of Choroidal Metastasis from Small-Cell Lung Carcinoma

Choroidal metastasis, Illustration, Ocular metastasis, Small-cell lung carcinoma, Thoracic computed tomography, Visual disturbance

2018 Jul

Manami Inoue, Takeshi Saraya*, Miku Oda, Masachika Fujiwara and Hajime Takizawa
Bilateral Symmetric Thalamic Metastasis in a Patient with Small Cell Lung Cancer

Brain metastasis, Chemotherapy, Illustration, Small cell lung cancer, Symmetric numbness, Thalamic metastasis

2018 Jul

Takeshi Saraya*, Chie Shimura, Sayuki Inaoka and Hajime Takizawa

cancer, Editorial, Mutations, p27

2018 May

Qiwei Yang* and Ayman Al-Hendy

Case Report, Mucinous, Urachal remnant

2018 Feb

Kanchan K. Palial*, Bob Yang, Philip J. S. Charlesworth, Charles E. Lewis, Lisa Browning and Clare Verrill
Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy

Case Study, Dosimetric, Radiation, Stereotactic body radiotherapy (SBRT)

2018 Jan

Jennifer Sims-Mourtada*, Serguei Casteneda, David Huang, John McGlade, Sunjay Shah, Lindsay Romak, Adam Raben and Firas Mourtada
Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq Data

LASSO, LUAD, LUSC, Original Research, Principal Components

2017 Sep

Zhengyan Huang, Li Chen and Chi Wang*

cancer, Dysadherin, Editorial, Oesophageal Cancer

2017 Jul

Alexandros Charalabopoulos* and Theodoros Liakakos

Biomarkers, Disease detection, Energy metabolism, Letter to the Editor, Metabolic syndrome, Mitochondrial DNA

2017 May

Vasudeva G. Kamath*

Editorial, Molecular Imaging, Molecular Medicine

2017 Jan

Pradeep K. Garg*
Rounding Down Chemotherapeutic Agents to the Nearest Vial Size as a Cost Containment Measure

Chemotherapy wastage, Cost-saving, Dose rounding, Original Research

2016 Oct

Yousef Al-Olah, Nasser Mahdi Al-Qhtani*, Maj Mohammed A. Al Waheeby, Abdul-Rahman I. Al-Ghamdi, Ghadah Al Yousif, Al Hanouf N. Al Dajani, Nourah M. Al Henaki and Ahlam M. Al Zahrani
Prostate Cancer Trends in Developing Countries

cancer, Cancer Trends, Developing Countries, Editorial, Prostate Cancer, Prostate Cancer Trends

2016 Sep

Aleyamma Mathew and Francis V. James*
Gastrointestinal Stromal Tumors: Innovation from Diagnosis

Gastrointestinal Stromal Tumors (GIST), Innovation, Observational Study, Target therapies

2016 Apr

Joana Espiga de Macedo*, Sílvia Lopes, Mónica Pinho and Pedro Santos

Epidermal growth factor receptor (EGFR), Head and neck-targeted therapy, Original Research

2016 Mar

Cessal Thommachan Kainickal*, Aparna M. P., Rejnish Kumar Ravi Kumar, Malu Rafi and Kunnambath Ramadas
The Proportion of ALDEFLUOR-Positive Cancer Stem Cells

ALDEFLUOR, Cancer stem cells, Density, Original Research

2015 Dec

Lynn M. Opdenaker, Shirin R. Modarai and Bruce M. Boman*

Mini Review, Radiotherapy, Treatment, Tumors

2015 Nov

Milan Anjanappa, Cessal Thommachan Kainickal and Francis V. James*

Boosting Response, Editorial, Immunotherapy, Impact of Immune Checkpoint Inhibitors, Radiation Treatment

2015 Sep

Firas Mourtada and Jennifer Sims-Mourtada*
Skin Hypopigmentation in a Patient with Papillary Carcinoma

Case Report, Hypopigmentation, Sorafenib, Thyroid Carcinoma

2015 Aug

Athira Raju, Mathews Jose, Arun Philip and Keechilat Pavithran*

Gastrointestinal Stromal Tumors (GISTs), Imatinib, Molecular Signaling Pathways, Opinion, Treatment, Tumor Heterogeneity

2015 Aug

Joana Espiga de Macedo*

cancer, Checkpoint inhibitors, Cytokines, Immuno-oncology, Immunotherapy, Impact of Immune Checkpoint Inhibitors, Letter to the Editor

2015 Jul

Anoop Kumar*
Long Term Low Dose Genistein decreases Stem Cell Populations

Genistein, Inflammatory breast cancer, Short Communication

2015 Mar

Jennifer Sims-Mourtada*, Lynn M. Opdenaker, Joshua Davis and Changqing Wu
MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin

Apoptosis, Cisplatin, Gastric cancer, Original Research

2015 Mar

Zhan-Guo Zhang, Yan-Hui Wu, Hui-Fang Liang, Bi-Xiang Zhang and Wan-Guang Zhang*

cancer, Flavones, Flavonols, review, Xenografts

2015 Mar

Mark F. McCarty*
Elimination of Tumor Suppressor Proteins during Liver Carcinogenesis

Gankyrin, Liver cancer, review, Tumor suppressor genes

2014 Dec

Nikolai A. Timchenko* and Kyle Lewis
Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro

Fibrosarcoma, Microenvironment, Original Research

2014 Nov

Irit Levinger, Racheli Zagouri, Yvonne Ventura and Razi Vago*
Role of Molecular Imaging in Oncology

Antibody, Editorial, Imaging, Tumor

2014 Jul

Pradeep K. Garg*, Surinder K. Batra and Sudha Garg
Application of Radionuclides and Antibody -Drug Conjugates to Target Cancer

Monoclonal antibody, Radionuclide therapy, review, Targeted alpha therapy

2014 Apr

Sean L. Kitson*
Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

AKT, Mini Review, p53, Protein degradation, PTEN

2014 Apr

Yasuko Kitagishi*, Satoru Matsuda*, Akari Minami, Yuna Ono, Atsuko Nakanishi and Yasunori Ogura

Special Editions

Cancer Studies and Molecular Medicine – Open Journal [ISSN 2377-1518] is an open-access, peer-reviewed medical research journal that publishes articles on all aspects of cancer research, with a focus on molecular and cellular mechanisms. The journal is committed to rapid publication and high-quality scientific content.

The journal covers a wide range of topics, including:

  • Cancer biology: This includes articles on the molecular and cellular mechanisms of cancer development, progression, and metastasis.
  • Cancer genetics and genomics: This includes articles on the identification and characterization of genetic and genomic alterations that contribute to cancer.
  • Cancer therapy: This includes articles on the development and evaluation of new cancer treatments, such as targeted therapies, immunotherapy, and gene therapy.
  • Cancer prevention and early detection: This includes articles on the identification of risk factors for cancer and the development of new methods for early detection.
  • Cancer epidemiology and statistics: This includes articles on the incidence, prevalence, and survival of different types of cancer.

 

This esteemed journal boasts a diverse and distinguished editorial board of leading experts in cancer research, ensuring the highest standards of scientific rigor and peer review.

The journal also publishes review articles, editorials, and letters to the editor.

Cancer Studies and Molecular Medicine – Open Journal (CSMMOJ) is a valuable resource for scientists, clinicians, and students who are interested in all aspects of cancer research. The journal’s open-access format makes it freely available to everyone, which can help to accelerate the pace of cancer research and improve the lives of cancer patients.

Our Commitment to Diversity, Equity, Inclusion, and Accessibility Capacity (DEIAC)

At Openventio, we are committed to promoting Diversity, Equity, Inclusion, and Accessibility Capacity (DEIAC) in all aspects of our publication. We believe that DEIAC is essential for advancing scientific knowledge and improving health outcomes for all. We strive to create a publication environment that is open, fair, respectful, and representative of the diversity of the scholarly community and society at large. We adhere to the Principles of Transparency and Best Practices in Scholarly Publishing and follow the guidance and recommendations from various resources on DEIAC in scholarly publishing. We welcome and support the participation and contribution of authors, editors, reviewers, and readers from diverse backgrounds, perspectives, and experiences. We also monitor and evaluate the impact and effectiveness of our DEIAC policies and practices, and seek to continuously improve them.

editor-in-chief

Pradeep Garg is an Editor-in-Chief of Cancer Studies and Molecular Medicine – Open Journal at Openventio Publishers.

Pradeep Garg, PhD

Center for Molecular Imaging and Therapy (CMIT) — Shreveport

Associate editors

JENNIFER SIMS-MOURTADA is an Associate Editor of Cancer Studies and Molecular Medicine – Open Journal at Openventio Publishers.

Jennifer Sims-Mourtada, PhD

Center for Translational Cancer Research, Helen F. Graham Cancer Center

editors

Somayeh Vafaei, PhD

Department of Obstetrics & Gynecology, University of Chicago

Website

Unnati M. Pandya, PhD

Discovery Biology, Exo Therapeutics, Inc.

Website

Masahiko Tanabe, MD, PhD

Department of Breast and Endocrine Surgery, The University of Tokyo Hospital

Website

Francis V. James, MD

Department of Radiation Oncology, Regional Cancer Centre

Website

Keechilat Pavithran, DM, MD

Department of Medical Oncology and Hematology, Amrita Vishwa Vidyapeetham

Website

Jian Pan, PhD

Department of Hematology and Oncology, Childrens Hospital of Soochow University

Website

Sajeed A. Rahuman, DM(RT), MD(RT)

Department of Radiation Oncology, Regional Cancer Centre

Website

Khalid Al-Nedawi, PhD

Department of Medical Sciences, McMaster University

Website

Ramachandran Murali, PhD

Department of Biomedical Sciences, Cedars-Sinai Medical Center

Website

Li Chen, PhD

Department of Biostatistics, University of Kentucky

Website

Daniel D. Taub, PhD

Washington DC VA Medical Center

Website

Alexandros Charalabopoulos, MD, PhD

National & Kapodistrian University of Athens

Website

Gokul Das, PhD

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute

Website

Shreya Kanodia, PhD

Department of Biomedical Sciences, MD Anderson Cancer Center

Website

Young K. Chae, MD, MPH, MBA

Feinberg School of Medicine, Northwestern University

Website

Sun-Young Kong, MD, PhD

Department of Cancer Biomedical Science, National Cancer Center Korea

Website

Saeed Sadeghi, MD

UCLA Santa Monica Hematology-Oncology Community Practice Group

Website

Chatchawin Assanasen, MD

Division of Hematology-Oncology, UT Health San Antonio

Website

Myriam N. Bouchlaka, PhD

Immuno-Oncology/Pharmacology at OncoResponse Inc.

Website

Frank S. Lieberman, MD

Department of Neurology, University of Pittsburgh School of Medicine

Website

Walter A. Hall, MD, MBA

Norton College of Medicine, SUNY Upstate Medical University

Website

reviewers

Necy S. Juat, MD

National Kidney and Transplant Institute, Philippines

Namrata Jayanth, PhD

Bristol Myres Squibb Research Centre, India

Astha Malik, PhD

Cincinnati Children’s Hospital Medical Center, USA

Poorva Sandlesh, PhD

University of Pennsylvania, USA

Jeanette Reece, PhD, MPH

University of Melbourne, Australia

Asha Eapen, PhD

University of Illinois, USA

Pavan Rajanahalli, PhD

University of Tampa, USA

Oorvashi R. Puli, PhD

University of Dayton, Australia

Shubha Ghosh, PhD

University of California Los Angeles, USA

Yan P. Yu, MD, PhD

University of Pittsburgh, USA

Zhong Liu, PhD

NovaRock Biotherapeutics Ltd, USA

Karel Petrak, MSc, DPhil

NangioTx, Inc, USA

QIN LI, MD

University of Texas, USA

Jennifer L. Bishop, PhD

The University of British Columbia, Canada

James J. Yu, PhD

Harvard Medical School, USA

Supriya Sen, PhD

University of California Los Angeles, USA

Tao Wang, PhD

UT Southwestern Medical Center, USA

Tsai Ming-Ming, PhD

Chang-Gung University of Science and Technology, Taiwan

Feedback Corner

Karel Petrak, DPhil is an author at Openventio Publishers

NangioTx Inc., — CSMMOJ

5/5

The process of publishing my manuscript by Cancer Studies and Molecular Medicine — Open Journal went smoothly, as promised. My manuscript was accepted for publication following a peer review. Subsequently, I was guided in reviewing the galley proof, providing corrections, and finalizing the manuscript. The manuscript was published without any delay.

Abolaji S. Olagunju, MSc is an author at Openventio Publishers

University of Ibadan - CSMMOJ

5/5

Writing a manuscript is one thing, getting a good publisher/Journal is another thing entirely. I appreciate Cancer Studies and Molecular Medicine for finding my article worthy of publishing. Perfect review process and good communication with authors.

Vincent M. Riccardi, MD, MBA is an author at Openventio Publishers

The Neurofibromatosis Institute - CSMMOJ

5/5

NF1 is an important disease, respecting the huge numbers of patients and the insights that the disorder and the gene have for other human situations. This disorder has been my focus for 48 years. I was pleased to share such thoughts through Cancer Studies & Molecular Medicine – Open Journal.

Daniel Gandia, MD is an author at Openventio Publishers

Clinical Oncologist - CSMMOJ

5/5

Cancer Studies and Molecular Medicine – Open Journal is an eye-opener to publish with. The reviewers are highly qualified and their comments were accepted by me in order to organize a better structure and add something more in the paper. Happy to have my first paper in this journal.

Alexandros Charalabopoulos, MD, PhD is an author at Openventio Publishers

Broomfield Hospital – CSMMOJ

5/5

Having published my research with Openventio I can without any doubt state that their professionalism is of a high standard as their Journals continuously try to make the academic world better with benefit to both researchers and patients.

connect with us

Indexed in